跳至主要内容
临床试验/NCT06067412
NCT06067412已完成不适用

Efficacy of Phenytoin vs Levetiracetam in Status Epilepticus at Institute of Child Health,Faisalabad

Shaheed Zulfiqar Ali Bhutto Medical University1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2022年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
70
试验地点
1
主要终点
To compare the efficacy of phenytoin and Levetiracetam in status epilepticus in children.

研究概览

简要总结

Status epilepticus is the second most common neurologic emergency in children. Morbidity and mortality are considerable; thus, timely termination of convulsive status epilepticus is the primary goal of management to avoid these risks Our objective was to compare the efficacy of phenytoin and Levetiracetam in status epilepticus in children.

This study was done in the pediatric emergency department of Children Hospital Faisalabad.

A total of 70 patients were randomly allocated to one of the groups by a computer-generated random number table according to their admission in an emergency. Children in group A were given levetiracetam. Children in group B were given I/V phenytoin. For both groups if seizures recurred after the first loading dose an additional 10mg/kg of the same drug was given over 10 minutes.

The patients were monitored to see whether there was any recurrence of seizure activity in the subsequent 24 hours. Seizure control was defined as the absence of seizure within 24 hours after the initial loading of the drug.

详细描述

OPERATIONAL DEFINITION

Status Epilepticus:

It is defined as continuous seizure activity or recurrent seizure activity without regaining of consciousness lasting for more than 5 minutes.

Efficacy:

Efficacy means control of seizures without supplemental aid of either medication or no recurrence with in twenty-four hours.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
6 Months 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Participants on any antiepileptic drug (AED) or having allergic reaction towards phenytoin or Levetiracetam were excluded from the study.
  • Non convulsive status epilepticus,
  • Absence status epilepticus,
  • Myoclonic status epilepticus were excluded.

研究组 & 干预措施

levetiracetam

Active Comparator

levetiracetam at a dose of 30 mg/kg diluted in 50 ml of normal saline in 15 minutes followed by a maintenance dose of 30mg/kg/day divided in two doses 12 hours apart after initial loading dose.

if seizures recurred after the first loading dose an additional 10mg/kg of the same drug was given over 10 minutes. If seizures recurred, the patients were loaded with sodium valporate 30 mg/kg diluted in 50 ml normal saline in 15 minutes.

干预措施: Levetiracetam (Drug)

phenytoin

Active Comparator

I/V phenytoin at 20 mg/kg diluted in 50ml normal saline in 15 minutes followed by maintenance dose of 5 mg/kg/day divided in two doses 12 hours apart.

if seizures recurred after the first loading dose an additional 10mg/kg of the same drug was given over 10 minutes. If seizures recurred, the patients were loaded with sodium valporate 30 mg/kg diluted in 50 ml normal saline in 15 minutes.

干预措施: Phenytoin (Drug)

结局指标

主要结局

To compare the efficacy of phenytoin and Levetiracetam in status epilepticus in children.

时间窗: Six months

Others parameters which include level of consciousness (GCS), heart rate in Bpm, respiratory rate per minute, blood pressure with sphygnomanometer and oxygen saturation with pulse oximeter was noted first at the time of admission and then again at 30 minutes, 1hour, 6hour, 12hour and 24 hours.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ali Raza Chaudhry

Senior Registrar Paediatric Surgery

Rawalpindi Medical College

研究点 (1)

Loading locations...

相似试验